Solomon Rotimi, PhD
@solomonrotimi.bsky.social
Scientist | Cancer Scientist | Clinical Biochemist | African Cancer Genomics Expert | Fulbrighter
EXCITING ANNOUNCEMENT
Our study on BRCA1/2 variants in Nigerian breast cancer patients is now accepted in Technology in Cancer Research & Treatment @tcrtcancer.bsky.social
#BRCA #BreastCancer #healthEquity
Our study on BRCA1/2 variants in Nigerian breast cancer patients is now accepted in Technology in Cancer Research & Treatment @tcrtcancer.bsky.social
#BRCA #BreastCancer #healthEquity
April 1, 2025 at 9:45 PM
EXCITING ANNOUNCEMENT
Our study on BRCA1/2 variants in Nigerian breast cancer patients is now accepted in Technology in Cancer Research & Treatment @tcrtcancer.bsky.social
#BRCA #BreastCancer #healthEquity
Our study on BRCA1/2 variants in Nigerian breast cancer patients is now accepted in Technology in Cancer Research & Treatment @tcrtcancer.bsky.social
#BRCA #BreastCancer #healthEquity